Abstract
Recombinant DNA technology has opened up a novel field for the agricultural biotechnologists to explore and design custom-made crops with specific trait(s). In addition to enhancing yield, transgenic plants are designed to have enhanced defense against pathogens, remove toxic compounds from the soil, to be tolerant to environmental stresses, to be live bioreactors to produce pharmaceuticals, to have improved nutritional features reflecting changes in protein, oil or vitamin content or to have woody species with lower generation time. But all plants with novel characters come with a price. The objective of the article is to evaluate the utility of the transgenic plants with respect to their novel features, the economic implications, seed security, agricultural sustainability and food safety. The gene mapping program of Arabidopsis and rice gives rise to the ethical question of the commercial patentability of the bioengineered plants. The impact of this science on agriculture that is being faced by the world with special reference to the developing countries of Asia is being discussed.
Keywords: Arabidopsis, Agrobacterium, DISEASE, Bacillus thuringensis, (Cydia pomonella), (Ostrinia nubilalis), (Leptinotarsa decemlineata)., Photorhabdus lumnescens, Ustilago maydis, Halobacterium halobium
Current Genomics
Title: Bioengineered Crops: The Commercial and Ethical Considerations
Volume: 2 Issue: 2
Author(s): Susmita Sengupta, L. K. Sengupta and P. S. Bisen
Affiliation:
Keywords: Arabidopsis, Agrobacterium, DISEASE, Bacillus thuringensis, (Cydia pomonella), (Ostrinia nubilalis), (Leptinotarsa decemlineata)., Photorhabdus lumnescens, Ustilago maydis, Halobacterium halobium
Abstract: Recombinant DNA technology has opened up a novel field for the agricultural biotechnologists to explore and design custom-made crops with specific trait(s). In addition to enhancing yield, transgenic plants are designed to have enhanced defense against pathogens, remove toxic compounds from the soil, to be tolerant to environmental stresses, to be live bioreactors to produce pharmaceuticals, to have improved nutritional features reflecting changes in protein, oil or vitamin content or to have woody species with lower generation time. But all plants with novel characters come with a price. The objective of the article is to evaluate the utility of the transgenic plants with respect to their novel features, the economic implications, seed security, agricultural sustainability and food safety. The gene mapping program of Arabidopsis and rice gives rise to the ethical question of the commercial patentability of the bioengineered plants. The impact of this science on agriculture that is being faced by the world with special reference to the developing countries of Asia is being discussed.
Export Options
About this article
Cite this article as:
Sengupta Susmita, Sengupta K. L. and Bisen S. P., Bioengineered Crops: The Commercial and Ethical Considerations, Current Genomics 2001; 2 (2) . https://dx.doi.org/10.2174/1389202013351011
DOI https://dx.doi.org/10.2174/1389202013351011 |
Print ISSN 1389-2029 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5488 |
Call for Papers in Thematic Issues
Advanced Computational Algorithms and Artificial Intelligence in Clinical Pharmacogenomics
In the era of personalized medicine, understanding the relationship between genetics and drug response is crucial. This issue delves into innovative methodologies, leveraging deep computational analysis and artificial intelligence, to enhance the field of Clinical Pharmacogenomics. The interdisciplinary approach harnesses the power of advanced high-throughput genotyping technologies, sophisticated computational analysis, ...read more
Applications of Single-cell Sequencing Technology in Reproductive Medicine
Single cell sequencing (SCS) technology utilizes individual cells' genetic material to sequence their genome, transcriptome, and epigenetics at the molecular level. It offers insights into cell heterogeneity and enables the study of limited biological materials. Since its recognition as a valuable technique in 2011, single cell sequencing has yielded numerous ...read more
Big Data in Cancer Research
Cancer is a significant threat to human life and health, remaining a highly aggressive killer. It is a leading cause of death worldwide and represents a crucial medical issue for humanity. However, in the past decade, the effectiveness of new synthetic anticancer agents has not matched the current clinical speculation. ...read more
Current Genomics in Cardiovascular Research
Cardiovascular diseases are the main cause of death in the world, in recent years we have had important advances in the interaction between cardiovascular disease and genomics. In this Research Topic, we intend for researchers to present their results with a focus on basic, translational and clinical investigations associated with ...read more
Related Journals
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Bacteria and Bacterial Toxins as Therapeutic Agents for Solid Tumors
Current Cancer Drug Targets Targeting Translation for Treatment of Cancer - A Novel Role for IRES?
Current Cancer Drug Targets Galactolipids as Potential Health Promoting Compounds in Vegetable Foods
Recent Patents on Food, Nutrition & Agriculture Natural Products Derived from Traditional Chinese Medicine as Novel Inhibitors of the Epidermal Growth Factor Receptor
Combinatorial Chemistry & High Throughput Screening Environmental Exposure, and Other Behavioral Risk Factors in Breast Cancer
Current Cancer Therapy Reviews Cucurbitacin E, An Experimental Lead Triterpenoid with Anticancer, Immunomodulatory and Novel Effects Against Degenerative Diseases. A Mini-Review
Current Topics in Medicinal Chemistry Bioinformatics Tools for Mass Spectroscopy-Based Metabolomic Data Processing and Analysis
Current Bioinformatics Subject Index To Volume 7
Current Pharmaceutical Biotechnology Synthesis, Biochemical Evaluation and Rationalisation of a Series of (3-O-Sulfonate) Derivatives of Estrone (E1) as Probes of the Active Site of Type 3 of the 17β-Hydroxysteroid Dehydrogenase (17β-HSD) Family of Enzymes
Letters in Drug Design & Discovery Acknowledgements to Reviewers
Current Cancer Drug Targets Adsorption of Antifungal Drugs Inside Pristine and Functionalized Fullerenes and Nanotubes: DFT Investigation
Current Computer-Aided Drug Design Comparative Binding Analysis of Monoclonal Antibodies Against Native and Mutant Type in ErbB2 Receptor: A Theoretical Modeling Approach
Current Pharmaceutical Biotechnology Biomarkers for Early Detection of Liver Cancer: Focus on Clinical Evaluation
Protein & Peptide Letters Drug Targeting of Estrogen Receptor Signaling in the Cardiovascular System: Preclinical and Clinical Studies
Current Medicinal Chemistry - Cardiovascular & Hematological Agents Quantitative Determination and Validation of Four Phenolic Acids in <i>Salvia Miltiorrhiza</i> Bunge using <sup>1</sup>H-NMR Spectroscopy
Current Pharmaceutical Analysis Design and Synthesis of a (N-Alkylaminoalkyl-Substituted)Arylalkenylamide Drug Discovery Library
Letters in Drug Design & Discovery The Ayurvedic Bhasma: The Ancient Science of Nanomedicine
Recent Patents on Nanomedicine Editorial [Hot Topic: Targeted Therapy for Glioblastoma Multiforme (Guest Editor: Marc-Eric Halatsch)]
Anti-Cancer Agents in Medicinal Chemistry Biosynthesis of Selenium Nanoparticle by Whole Cells of Saccharomyces boulardii and its Evaluation as Anticancer Agent
Current Nanoscience The Wnt Pathway: Emerging Anticancer Strategies
Recent Patents on Endocrine, Metabolic & Immune Drug Discovery